C-reactive protein and colorectal adenoma in the CLUE II cohort
- 107 Downloads
Circulating C-reactive protein concentration has been associated with colorectal cancer in some studies. Whether C-reactive protein is associated with earlier steps in the natural history of this cancer has not been published (aside from an abstract). Thus, we evaluated the association between plasma C-reactive protein concentration and development of colorectal adenoma in a nested case–control study.
Colorectal adenoma cases (n = 135) and matched controls (n = 269) who had a negative sigmoidoscopy or colonoscopy were identified between baseline in 1989 and 2000 from among participants in the CLUE II cohort of Washington County, Maryland. Cases were confirmed by medical record review. Controls were matched with cases on age, sex, race, date of blood draw, time since last meal, and type of endoscopy. The odds ratio (OR) of adenoma was estimated from conditional logistic regression models.
C-reactive protein concentrations were similar between colorectal adenoma cases and controls (median C-reactive protein, 1.31 vs. 1.38 mg/l; p = 0.13). The OR of colorectal adenoma among those in the highest fourth (>2.95 mg/l) of C-reactive protein concentration compared with the lowest fourth (<0.65 mg/l) was 0.61 (95% confidence interval, 0.29–1.25; p for trend = 0.25).
Pre-diagnostic plasma C-reactive protein concentration was not associated with an increased risk of colorectal adenoma. More work is needed to determine whether C-reactive protein is a valid marker of intra-colonic inflammation, and whether such inflammation contributes to the etiology of colorectal neoplasia.
KeywordsC-reactive protein Inflammation Colorectal neoplasms Risk
We appreciate the continued efforts of the staff members at the Johns Hopkins George W. Comstock Center for Public Health Research and Prevention in the conduct of the CLUE II studies. We also thank Gary Bradwin, director of the Rifai laboratory. Financial support: American Institute for Cancer Research and the Maryland Cigarette Restitution Fund at Johns Hopkins University.
- 4.Janeway CA (2005) Immunobiology: the immune system in health and disease, 6th edn. Garland Science Publishing, New York, NY, pp 85–87Google Scholar
- 15.Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA (2007) C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Am J Epidemiol 165:S150Google Scholar
- 24.Ognjanovic S, Yamamoto J, Salzman B, Franke A, Le Marchand L (2006) The relationships of serum CRP and IL-6 levels with lifestyle factors, race/ethinity and colorectal adenoma risk. Proc Amer Assoc Cancer Res, Washington, DCGoogle Scholar
- 25.Pearson TA, Mensah GA, Alexander RW et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499–511PubMedCrossRefGoogle Scholar